Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.95 +0.22 (+1.28%)
As of: Oct 21, 2026 · 3:53 PM EDT

Aurinia Pharmaceuticals (AUPH) Receivables - Other (2019 - 2020)

Updated

Aurinia Pharmaceuticals (AUPH) reported Receivables - Other of $51,000 for Q4 2020, down 68.7% from $163,000 a year earlier.

Analysis

Aurinia Pharmaceuticals (AUPH) Receivables - Other (2019 - 2020) Analysis & Trends

  • By year, Receivables - Other came in at $163,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Aurinia Pharmaceuticals 2.20 Bn 632.51 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 51,000.00
Dec 31, 2019 163,000.00
API Access

Aurinia Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=AUPH&period=max&api_key=YOUR_API_KEY